News Focus
News Focus
Followers 308
Posts 37306
Boards Moderated 1
Alias Born 11/14/2013

Re: Investor082 post# 714089

Monday, 08/19/2024 12:36:45 AM

Monday, August 19, 2024 12:36:45 AM

Post# of 822926
Or, if DCVax-l approved, some company like a Regeneron would go all in on NWBO and make it worth everyone’s while. Some structure culminating in….

It’s a company ripe for buyout.
1. Strong Science.
2. Combo patents, Direct Patents, other patent applications (hyperactive DC) and patents associated with company it absorbed.
3. Very advanced automated closed system manufacturing, with loads of patents.
4. Universal cancer vaccine technology refined over the years.
5. Old management.

I know most BP don’t want to eventually cure anything, but some medium sized ones do.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News